HC Wainwright Boosts BridgeBio Pharma (NASDAQ:BBIO) Price Target to $53.00
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target hoisted by HC Wainwright from $49.00 to $53.00 in a research note issued to investors on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for BridgeBio Pharma’s Q1 2025 earnings at ($1.01) EPS, Q2 2025 earnings […]
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target hoisted by HC Wainwright from $49.00 to $53.00 in a research note issued to investors on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for BridgeBio Pharma’s Q1 2025 earnings at ($1.01) EPS, Q2 2025 earnings […]